Doctors state that Avandia is done with. It does not matter whether the Food and Drug Administration halts the sale of the drug but doctors state that no one would be prescribing it any longer.

Last week a meeting of FDA committee that comprised outside experts took place to provide advice on whether any regulatory action was needed. The FDA would however take some weeks to decide the fate of the drug.

But doctors have already stated what they wanted to say. Reports say that Avandia prescriptions have plummeted following concerns about whether the drug increased heart attack risk.

In the USA in June 2007, 5.6 million Avandia prescriptions were dispensed and it had already dropped to one million by May 2010.

According to an endocrinologist at the Mayo Clinic, Victor Montori, who wasn't an FDA panelist, informed that the drug was being taken by less than ten per cent of U.S. diabetes patients. Montori added, "If the FDA does not do anything, I think the market will continue to shrink."

The committees 33 panelists who voted were divided and 20 voted to keep the drug on the market but 50 per cent of these 20 recommended doing so only with tight restrictions.

Reports say that there could be a 95 per cent drop in prescriptions by U.S. doctors.

Endocrinologist Clifford Rosen said, "I'm telling you, the drug is done. Nobody should be prescribing it."